ALMR

Alamar Biosciences, Inc. ALMR

NasdaqMid CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$29.43M

Quarter to Jun 30

Net income

$-13.20M

Quarter to Jun 30

Free cash flow

$-14.96M

Quarter to Jun 30

Operating margin

-46.0%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$664.31M total
Sands Capital Ventures, LLC
$114.62M--
Samsara BioCapital, LLC
$67.19M--
T. Rowe Price Investment Management, Inc.
$59.67M--
ARK Investment Management LLC
$37.22M--
BRAIDWELL LP
$29.37M--
ALLIANCEBERNSTEIN L.P.
$27.17M--
Hillhouse Capital Advisors, Ltd.
$25.91M--
BlackRock, Inc.
$24.69M--
MILLENNIUM MANAGEMENT LLC
$23.45M--
FMR LLC
$22.47M--
PURA VIDA INVESTMENTS, LLC
$20.48M--
EMERALD ADVISERS, LLC
$17.53M--
Artisan Partners Limited Partnership
$16.63M--
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
$16.25M--
VANGUARD CAPITAL MANAGEMENT LLC
$12.55M--
FARALLON CAPITAL MANAGEMENT LLC
$12.54M--
WELLINGTON MANAGEMENT GROUP LLP
$12.41M--
EMERALD MUTUAL FUND ADVISERS TRUST
$11.44M--
AMERIPRISE FINANCIAL INC
$11.35M--
GEODE CAPITAL MANAGEMENT, LLC
$8.95M--
Woodline Partners LP
$6.59M--
NEW YORK STATE COMMON RETIREMENT FUND
$5.44M--
CITADEL ADVISORS LLC
$4.88M--
LORD, ABBETT & CO. LLC
$4.81M--
LMR Partners LLP
$4.74M--
See all 87 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Operating Margin

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/ALMR

Earnings Per Share

13fpro.ai/company/ALMR

Loading ratio trend…

ALMR insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Alamar Biosciences, Inc. (ALMR): stock profile, AI score and financials

Alamar Biosciences, Inc. (ALMR) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. ALMR is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q2 2026), Alamar Biosciences, Inc. reports quarterly revenue of $29.4M, net income of $-13.2M, an operating margin of -46.0%. Top institutional holders of ALMR by reported 13-F value include Sands Capital Ventures, Samsara BioCapital, T. Rowe Price Investment Management, based on the most recent SEC filings. ALMR trades on the Nasdaq exchange and files with the SEC under CIK 2104204. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ALMR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Alamar Biosciences, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 2104204 →